Hymn Mach
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Hymn Mach has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Alison Hamilton
Department of Pathology and Laboratory Medicine, University of Ottawa Ottawa, ON, Canada
1 shared publicationAyse E. Yilbas
Department of Cellular and Molecular Medicine, University of Ottawa Ottawa, ON, Canada
1 shared publication- Darryl Raymond Davis
Division of Cardiology, Department of Medicine, University of Ottawa and University of Ottawa Heart Institute , H-1285D, 40 Ruskin St. Ottawa, Ottawa Ontario K1Y 4W7
1 shared publication - Jihong Chen
Department of Pathology and Laboratory Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada
1 shared publication Natascha Lacroix
Department of Cellular and Molecular Medicine, University of Ottawa Ottawa, ON, Canada
1 shared publication- Qiao Li
Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Canada
1 shared publication
Latest Publications
- Open Access
- 14 March 2014
- Published by Frontiers Media SA in Frontiers in Chemistry
- Vol. 2, 12
Activation of GATA4 gene expression at the early stage of cardiac specification
Currently, there are no effective treatments to directly repair damaged heart tissue after cardiac injury since existing therapies focus on rescuing or preserving reversibly damaged tissue. Cell-based therapies using cardiomyocytes generated from stem cells present a promising therapeutic approach to directly replace damaged myocardium with new healthy tissue. However, the molecular mechanisms underlying the commitment of stem cells into cardiomyocytes are not fully understood and will be critical to guide this new technology into the clinic. Since GATA4 is a critical regulator of cardiac differentiation, we examined the molecular basis underlying the early activation of GATA4 gene expression during cardiac differentiation of pluripotent stem cells. Our studies demonstrate the direct involvement of histone acetylation and transcriptional coactivator p300 in the regulation of GATA4 gene expression. More importantly, we show that histone acetyltransferase (HAT) activity is important for GATA4 gene expression with the use of curcumin, a HAT inhibitor. In addition, the widely used histone deacetylase inhibitor valproic acid enhances both histone acetylation and cardiac specification.
- 14 March 2014
- Published by Frontiers Media SA in Frontiers in Chemistry
- Vol. 2, 12
Open AccessActivation of GATA4 gene expression at the early stage of cardiac specification
Currently, there are no effective treatments to directly repair damaged heart tissue after cardiac injury since existing therapies focus on rescuing or preserving reversibly damaged tissue. Cell-based therapies using cardiomyocytes generated from stem cells present a promising therapeutic approach to directly replace damaged myocardium with new healthy tissue. However, the molecular mechanisms underlying the commitment of stem cells into cardiomyocytes are not fully understood and will be critical to guide this new technology into the clinic. Since GATA4 is a critical regulator of cardiac differentiation, we examined the molecular basis underlying the early activation of GATA4 gene expression during cardiac differentiation of pluripotent stem cells. Our studies demonstrate the direct involvement of histone acetylation and transcriptional coactivator p300 in the regulation of GATA4 gene expression. More importantly, we show that histone acetyltransferase (HAT) activity is important for GATA4 gene expression with the use of curcumin, a HAT inhibitor. In addition, the widely used histone deacetylase inhibitor valproic acid enhances both histone acetylation and cardiac specification.